elafibranor 120mg

DRUG2 trials

Sponsors

Genfit

Conditions

Non Alcoholic SteatohepatitisNon-Alcoholic Fatty Liver

Phase 2

Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH)

TerminatedNCT03883607

GenfitNon Alcoholic Steatohepatitis

Start: 2019-06-25End: 2020-06-16Updated: 2021-10-28

Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)

TerminatedNCT03953456

GenfitNon-Alcoholic Fatty Liver

Start: 2019-08-16End: 2020-07-14Updated: 2020-08-31